Andrew S. Murkin

1.3k total citations
33 papers, 985 citations indexed

About

Andrew S. Murkin is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Andrew S. Murkin has authored 33 papers receiving a total of 985 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 10 papers in Epidemiology and 9 papers in Physiology. Recurrent topics in Andrew S. Murkin's work include Biochemical and Molecular Research (21 papers), Adenosine and Purinergic Signaling (9 papers) and Enzyme Structure and Function (6 papers). Andrew S. Murkin is often cited by papers focused on Biochemical and Molecular Research (21 papers), Adenosine and Purinergic Signaling (9 papers) and Enzyme Structure and Function (6 papers). Andrew S. Murkin collaborates with scholars based in United States, Canada and Australia. Andrew S. Murkin's co-authors include Vern L. Schramm, S. Ray, Peter C. Tyler, Rafael G. da Silva, Gary B. Evans, Martin E. Tanner, Richard H. Furneaux, Patrick Fernandez, Andrew M. Gulick and Erika A. Taylor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Andrew S. Murkin

33 papers receiving 971 citations

Peers

Countries citing papers authored by Andrew S. Murkin

Since Specialization

Citations

This map shows the geographic impact of Andrew S. Murkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew S. Murkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew S. Murkin more than expected).

Fields of papers citing papers by Andrew S. Murkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew S. Murkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew S. Murkin. The network helps show where Andrew S. Murkin may publish in the future.

Co-authorship network of co-authors of Andrew S. Murkin

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew S. Murkin. A scholar is included among the top collaborators of Andrew S. Murkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew S. Murkin. Andrew S. Murkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Kinetic characterization of methylthio-d-ribose-1-phosphate isomerase 2023 ·Methods in enzymology on CD-ROM/Methods in enzymology ·(unknown), (unknown), Andrew S. Murkin	2
2	Covalent Adduct Formation in Methylthio-d-ribose-1-phosphate Isomerase: Reaction Intermediate or Artifact? 2022 ·Biochemistry ·(unknown), (unknown), Andrew S. Murkin	1
3	α-Ketol and α-iminol rearrangements in synthetic organic and biosynthetic reactions 2021 ·Beilstein Journal of Organic Chemistry ·(unknown), Andrew S. Murkin	9
4	New Electrophiles and Strategies for Mechanism-Based and Targeted Covalent Inhibitor Design 2019 ·Biochemistry ·S. Ray, Andrew S. Murkin	66
5	Mechanism-based inactivator of isocitrate lyases 1 and 2 from Mycobacterium tuberculosis 2017 ·Proceedings of the National Academy of Sciences ·(unknown), Andrew S. Murkin, (unknown), Lawrence D. Harris, Peter C. Tyler, (unknown), James C. Sacchettini, (unknown), Thomas D. Meek	32
6	Mechanism and inhibition of 1-deoxy-d-xylulose-5-phosphate reductoisomerase 2014 ·Bioorganic Chemistry ·Andrew S. Murkin, (unknown), (unknown)	26
7	Transition-State-Guided Drug Design for Treatment of Parasitic Neglected Tropical Diseases 2014 ·Current Medicinal Chemistry ·Andrew S. Murkin, Mary M. Moynihan	3
8	Alteration of the Flexible Loop in 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase Boosts Enthalpy-Driven Inhibition by Fosmidomycin 2014 ·Biochemistry ·(unknown), Gregory Tombline, Juan Liu, (unknown), C. Leigh Allen, Andrew M. Gulick, Andrew S. Murkin	9
9	DXP Reductoisomerase: Reaction of the Substrate in Pieces Reveals a Catalytic Role for the Nonreacting Phosphodianion Group 2013 ·Biochemistry ·(unknown), Andrew S. Murkin	20
10	Highly Precise Measurement of Kinetic Isotope Effects Using ¹H-Detected 2D [¹³C,¹H]-HSQC NMR Spectroscopy 2012 ·Journal of the American Chemical Society ·(unknown), Bharathwaj Sathyamoorthy, Alexander Eletsky, Thomas Szyperski, Andrew S. Murkin	30
11	Plasmodium falciparum Parasites Are Killed by a Transition State Analogue of Purine Nucleoside Phosphorylase in a Primate Animal Model 2011 ·PLoS ONE ·María B. Cassera, Keith Z. Hazleton, Emilio Merino, Nicanor Obaldía, (unknown), Andrew S. Murkin, (unknown), Jemy A. Gutierrez, Steven C. Almo, Gary B. Evans, Y.S. Babu, Vern L. Schramm	55
12	Femtosecond dynamics coupled to chemical barrier crossing in a Born-Oppenheimer enzyme 2011 ·Proceedings of the National Academy of Sciences ·Rafael G. da Silva, Andrew S. Murkin, Vern L. Schramm	97
13	Identification of Three Classes of Heteroaromatic Compounds with Activity against Intracellular Trypanosoma cruzi by Chemical Library Screening 2009 ·PLoS neglected tropical diseases ·Esther Bettiol, Marie I. Samanovic, Andrew S. Murkin, Jayne Raper, Frederick S. Buckner, Ana Rodrı́guez	68
14	Ribocation Transition State Capture and Rebound in Human Purine Nucleoside Phosphorylase 2009 ·Chemistry & Biology ·Mahmoud Ghanem, Andrew S. Murkin, Vern L. Schramm	12
15	Immucillins in custom catalytic-site cavities 2008 ·Bioorganic & Medicinal Chemistry Letters ·Andrew S. Murkin, Keith Clinch, Jennifer M. Mason, Peter C. Tyler, Vern L. Schramm	13
16	Azetidine Based Transition State Analogue Inhibitors of N-Ribosyl Hydrolases and Phosphorylases 2008 ·Journal of Medicinal Chemistry ·Gary B. Evans, Richard H. Furneaux, Ben W. Greatrex, Andrew S. Murkin, Vern L. Schramm, Peter C. Tyler	74
17	Transition-State Interactions Revealed in Purine Nucleoside Phosphorylase by Binding Isotope Effects 2008 ·Journal of the American Chemical Society ·Andrew S. Murkin, Peter C. Tyler, Vern L. Schramm	20
18	l -Enantiomers of Transition State Analogue Inhibitors Bound to Human Purine Nucleoside Phosphorylase 2007 ·Journal of the American Chemical Society ·Agnes Rinaldo-Matthis, Andrew S. Murkin, U.A. Ramagopal, Keith Clinch, Simon Mee, Gary B. Evans, Peter C. Tyler, Richard H. Furneaux, Steven C. Almo, Vern L. Schramm	19
19	Neighboring Group Participation in the Transition State of Human Purine Nucleoside Phosphorylase 2007 ·Biochemistry ·Andrew S. Murkin, Matthew R. Birck, Agnes Rinaldo-Matthis, Wuxian Shi, Erika A. Taylor, Vern L. Schramm	45
20	Phosphate Activation in the Ground State of Purine Nucleoside Phosphorylase 2006 ·Journal of the American Chemical Society ·Hua Deng, Andrew S. Murkin, Vern L. Schramm	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact